D. E. Shaw & Co., Inc. Axsome Therapeutics, Inc. Transaction History

D. E. Shaw & Co., Inc.

$100 Billion
Q1 2025

A detailed history of D. E. Shaw & Co., Inc. transactions in Axsome Therapeutics, Inc. stock. As of the latest transaction made, D. E. Shaw & Co., Inc. holds 547,665 shares of AXSM stock, worth $60.3 Million. This represents 0.06% of its overall portfolio holdings.

Number of Shares

547,665

Previous 20,346 2591.76%

Holding current value

$60.3 Million

Previous $1.72 Million 3611.45%

% of portfolio

0.06%

Previous 0.0%

18 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2025 May 15, 2025	BUY	$80.05 - $137.75 $42.2 Million - $72.6 Million	527,319 Added 2591.76%	547,665 $63.9 Million
Q4 2024 Feb 14, 2025	BUY	$83.08 - $100.49 $1.45 Million - $1.75 Million	17,446 Added 601.59%	20,346 $1.72 Million
Q3 2024 Nov 14, 2024	SELL	$78.93 - $95.84 $271,045 - $329,114	-3,434 Reduced 54.22%	2,900 $260,000
Q2 2024 Aug 14, 2024	SELL	$65.72 - $80.5 $94,308 - $115,517	-1,435 Reduced 18.47%	6,334 $509,000
Q1 2024 May 15, 2024	SELL	$69.39 - $97.64 $98,186 - $138,160	-1,415 Reduced 15.41%	7,769 $619,000
Q4 2023 Feb 14, 2024	BUY	$57.42 - $83.61 $527,345 - $767,874	9,184 New	9,184 $730,000
Q2 2022 Aug 15, 2022	SELL	$21.74 - $46.75 $3.23 Million - $6.95 Million	-148,630 Reduced 95.65%	6,762 $259,000
Q1 2022 May 16, 2022	BUY	$23.7 - $41.39 $3.35 Million - $5.85 Million	141,453 Added 1014.8%	155,392 $6.43 Million
Q3 2021 Nov 15, 2021	SELL	$19.91 - $68.26 $181,380 - $621,848	-9,110 Reduced 39.52%	13,939 $459,000
Q2 2021 Aug 16, 2021	SELL	$50.63 - $73.5 $514,856 - $747,421	-10,169 Reduced 30.61%	23,049 $1.56 Million
Q1 2021 May 17, 2021	SELL	$55.91 - $81.44 $7.49 Million - $10.9 Million	-133,964 Reduced 80.13%	33,218 $1.88 Million
Q4 2020 Feb 16, 2021	SELL	$66.31 - $86.52 $4.25 Million - $5.54 Million	-64,060 Reduced 27.7%	167,182 $13.6 Million
Q3 2020 Nov 16, 2020	SELL	$68.34 - $85.84 $304,864 - $382,932	-4,461 Reduced 1.89%	231,242 $16.5 Million
Q2 2020 Aug 14, 2020	SELL	$49.87 - $98.69 $6.13 Million - $12.1 Million	-122,992 Reduced 34.29%	235,703 $19.4 Million
Q1 2020 May 15, 2020	BUY	$41.2 - $101.31 $11.3 Million - $27.9 Million	275,232 Added 329.77%	358,695 $21.1 Million
Q4 2019 Feb 14, 2020	SELL	$16.71 - $106.24 $609,714 - $3.88 Million	-36,488 Reduced 30.42%	83,463 $8.63 Million
Q3 2019 Nov 14, 2019	BUY	$20.24 - $29.16 $1.72 Million - $2.48 Million	85,195 Added 245.12%	119,951 $2.43 Million
Q2 2019 Aug 14, 2019	BUY	$13.46 - $25.75 $467,815 - $894,967	34,756 New	34,756 $895,000

Others Institutions Holding AXSM

# of Institutions

409

Shares Held

36.6M

Call Options Held

751K

Put Options Held

568K

View Full List

About Axsome Therapeutics, Inc.

Ticker AXSM
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 42,878,000
Market Cap $4.72B
Description
Axsome Therapeutics, Inc., a biopharmaceutical company, engages in the development of novel therapies for central nervous system (CNS) disorders in the United States. The company's product pipeline includes AXS-05, a therapeutic for the treatment of major depressive disorder and resistant depression disorders; and that is in the Phase III clinic...

More about AXSM

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of D. E. Shaw & Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on D. E. Shaw & Co., Inc. with notifications on news.

Account